50
Participants
Start Date
February 28, 2010
Primary Completion Date
October 31, 2011
Study Completion Date
November 30, 2011
Dasatinib (Sprycel)
100mg of Dasatinib will be administered as tablets, by mouth, once a day (or twice in some cases depending on the stage of the disease) consistently either in the morning or evening for 12 months. Dose of Dasatinib will be modified according to the patients response.
University Hospital, Basel
E Herriot Hospital, Lyon
University Hospital, Hamburg
Uniklinik Leipzig, Leipzig
Stiftung Deutsche Klinik für Diagnostik, Wiesbaden
Hopitaux Universitaires de Geneve, Geneva
Hammersmith Hospital, London
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
European Society for Blood and Marrow Transplantation
NETWORK